Low-Molecular-Weight Heparin (Enoxaparin) vs Dextran 70: The Prevention of Postoperative Deep Vein Thrombosis After Total Hip Replacement

Archives of Internal Medicine

Volumn 151, Issue 8, 1991, Pages 1621-1624

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; DEXTRAN 70; ENOXAPARIN;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE STUDY; DEXTRANS; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HIP PROSTHESIS; HUMAN; MALE; MIDDLE AGE; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES; THROMBOPHLEBITIS;

EID: 0025910428     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400080105020     Document Type: Article

References (24)

1. Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925-929.
2. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost. 1988;60:407-410.
3. Lassen MR, Borris LC, Christiansen HM, et al. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery. Br J Surg. 1988;75:686-689.
4. Office of Medical Applications of Research, National Institutes of Health. Prevention of venous thrombosis and pulmonary embolism. JAMA. 1986;256:744-749.
5. Teien AN, Lie M. Evaluation of amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Thromb Res. 1977;10:399-410.
6. Rabinov K, Paulin S. Roentgendiagnosis of venous thrombosis in the leg. Arch Surg. 1972;104:134-144.
7. Zachrisson BE, Jansen H. Phlebographic signs in fresh postoperative venous thrombosis of the lower extremity. Acta Radiol. 1973;14:82-96.
8. Kim K, De Mets DL. Design and analysis of group sequential tests based on type I error spending rate function. Biometrika. 1987;74:149-154.
9. Zelen M. The analysis of several 2 by 2 contingency tables. Biometrika. 1971;58:129-137.
10. Metha C, Patel N, Wei L. Computing exact significance test with restricted randomization rules. Biometrika. 1988;75:295-302.
11. Eriksson BI, Zachrisson BE, Teger-Nilsson AC, Risberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg. 1988;75:1053-1057.
12. Bergqvist D, Burmark US, Frisell J, et al. Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily: a prospective trial on prevention of postoperative thrombosis. Br J Surg. 1986;73:204-208.
13. Bergqvist D, Mätzsch T, Burmark US, et al. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg. 1988;75:888-891.
14. Levine MN, Planes A, Hirsch J, Goodyear M, Vochelle N, Gent M. The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost. 1989;62:940-944.
15. Modig J, Borg T, Karlström G, Maripuu E, Sahlstedt B. Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth Analg. 1983;62:174-180.
16. Thorburn J, Louden JR, Vallance R. Spinal and general anaesthesia in total hip replacement: frequency of deep vein thrombosis. Br J Anaesth. 1980;52:1117-1120.
17. Scott NB, Kehlet H. Regional anaesthesia and surgical morbidity. Br J Surg. 1988;75:299-304.
18. Fredin H, Rosberg B. Anaesthetic techniques and thromboembolism in total hip arthroplasty. Eur J Anaesthesiol. 1986;3:273-281.
19. Bergqvist D. Postoperative Thromboembolism. Berlin, Federal Republic of Germany: Springer Verlag; 1983:129-134.
20. Ljungström K-G. Dextran prophylaxis of fatal pulmonary embolism. World J Surg. 1983;7:767-772.
21. Gruber UF, Salden T, Brokop T, et al. Incidence of fatal pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. Br Med J. 1980;280:69-72.
22. Salzman EW, Davies GC. Prophylaxis of venous thromboembolism: analysis of cost-effectiveness. Ann Surg. 1980;191:207-218.
23. De Angelis J. Hazards of subdural and epidural anaesthesia during anticoagulant therapy: a case report and review. Anesth Analg. 1972;51:676-679.
24. Scurr JH, Coleridge-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. BMJ. 1988;297:28.